Neuland Laboratories Ltd (NEULANDLAB) — Announcement | 9 September 2026
Neuland Laboratories announced its management will attend three upcoming investor meetings in September 2026, including sessions with Emkay Global and ICICI Securities in Hyderabad, as part of ongoing analyst engagement efforts.
About Neuland Laboratories Ltd (NEULANDLAB)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when NEULANDLAB files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NEULANDLAB — Free💡 Ask AI about this filing
📊 More NEULANDLAB filings
- Announcement — 25 September 2026Neuland Laboratories has closed its insider trading window effective October 1, 2026, until 48 hours...
- 🔴 Announcement — 16 September 2026Neuland Laboratories announced its management will attend the Goldman Sachs Global Healthcare CDMO D...
- 🔴 Announcement — 15 September 2026Neuland Laboratories announced that its first commercial peptide manufacturing module is now operati...
- 🟡 Board Meeting — 7 September 2026Neuland Laboratories announced on September 7, 2026, that its board approved ₹126 crores capital exp...
- 🔴 Announcement — 25 August 2026Neuland Laboratories Limited announced that CRISIL has reaffirmed its long-term rating at CRISIL A+ ...
🔥 Also filed on 9 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NEULANDLAB files new disclosures
Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NEULANDLAB — FreeFree account · 2 AI queries/day